Literature DB >> 15331400

The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing.

Traci A Wilgus1, Valerie K Bergdall, Kathleen L Tober, Kara J Hill, Srabani Mitra, Nicholas A Flavahan, Tatiana M Oberyszyn.   

Abstract

Cyclooxygenase-2 (COX-2) and the prostaglandin products generated as a result of COX-2 activity mediate a variety of biological and pathological processes. Scarless healing occurs in fetal skin in the first and second trimesters of development. This scarless healing process is known to proceed without a significant inflammatory response, which appears to be important for the lack of scarring. Because the COX-2 pathway is an integral component of inflammation, we investigated its role in the fetal repair process using a mouse model of scarless fetal wound healing. COX-2 expression in scarless and fibrotic fetal wounds was examined. In addition, the ability of exogenous prostaglandin E(2) to alter scarless fetal healing was evaluated. The results suggest that the COX-2 pathway is involved in scar production in fetal skin and that targeting COX-2 may be useful for limiting scar formation in adult skin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331400      PMCID: PMC1618587          DOI: 10.1016/S0002-9440(10)63338-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  61 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

2.  The effects of cyclooxygenase isozyme inhibition on incisional wound healing in mouse skin.

Authors:  Karin Müller-Decker; Wolfgang Hirschner; Friedrich Marks; Gerhard Fürstenberger
Journal:  J Invest Dermatol       Date:  2002-11       Impact factor: 8.551

3.  Studies in fetal wound healing, VI. Second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation.

Authors:  M T Longaker; D J Whitby; N S Adzick; T M Crombleholme; J C Langer; B W Duncan; S M Bradley; R Stern; M W Ferguson; M R Harrison
Journal:  J Pediatr Surg       Date:  1990-01       Impact factor: 2.545

4.  Control of scarring in adult wounds using antisense transforming growth factor-beta 1 oligodeoxynucleotides.

Authors:  B M Choi; H J Kwak; C D Jun; S D Park; K Y Kim; H R Kim; H T Chung
Journal:  Immunol Cell Biol       Date:  1996-04       Impact factor: 5.126

5.  Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.

Authors:  M N Muscará; W McKnight; S Asfaha; J L Wallace
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

6.  Reduction of scar formation in full-thickness wounds with topical celecoxib treatment.

Authors:  Traci A Wilgus; Yael Vodovotz; Elena Vittadini; Elizabeth A Clubbs; Tatiana M Oberyszyn
Journal:  Wound Repair Regen       Date:  2003 Jan-Feb       Impact factor: 3.617

7.  Effects of prostaglandins and indomethacin on the cellular inflammatory response following surgical trauma in fetal rabbits.

Authors:  M J Morykwas; S L Perry; L C Argenta
Journal:  Int J Tissue React       Date:  1993

8.  Immunohistochemical localization of growth factors in fetal wound healing.

Authors:  D J Whitby; M W Ferguson
Journal:  Dev Biol       Date:  1991-09       Impact factor: 3.582

9.  Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair.

Authors:  R Y Lin; K M Sullivan; P A Argenta; M Meuli; H P Lorenz; N S Adzick
Journal:  Ann Surg       Date:  1995-08       Impact factor: 12.969

10.  Acute coronary disease Athero-Inflammation: Therapeutic approach.

Authors:  Raul Altman
Journal:  Thromb J       Date:  2003-06-20
View more
  40 in total

1.  Innovative therapies in the treatment of keloids and hypertrophic scars.

Authors:  Martha H Viera; Sadegh Amini; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-05

2.  TGF-β1 related inflammation in the posterior longitudinal ligament of cervical spondylotic myelopathy patients.

Authors:  Jia-Zeng Wang; Xiu-Tong Fang; E Lv; Fang Yu; Zhen-Wei Wang; Hong-Xing Song
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 3.  Skin wound healing and scarring: fetal wounds and regenerative restitution.

Authors:  Cecelia C Yates; Patricia Hebda; Alan Wells
Journal:  Birth Defects Res C Embryo Today       Date:  2012-12

4.  The alarmin HMGB-1 influences healing outcomes in fetal skin wounds.

Authors:  Adrienne D Dardenne; Brian C Wulff; Traci A Wilgus
Journal:  Wound Repair Regen       Date:  2013-02-25       Impact factor: 3.617

Review 5.  Regenerative Scar-Free Skin Wound Healing.

Authors:  Mehri Monavarian; Safaa Kader; Seyedsina Moeinzadeh; Esmaiel Jabbari
Journal:  Tissue Eng Part B Rev       Date:  2019-08       Impact factor: 6.389

6.  Risk assessment of excess drug and sunscreen absorption via skin with ablative fractional laser resurfacing : optimization of the applied dose for postoperative care.

Authors:  Wei-Yu Chen; Chia-Lang Fang; Saleh A Al-Suwayeh; Hung-Hsu Yang; Yi-Ching Li; Jia-You Fang
Journal:  Lasers Med Sci       Date:  2013-01-06       Impact factor: 3.161

Review 7.  The Importance of Mast Cells in Dermal Scarring.

Authors:  Traci A Wilgus; Brian C Wulff
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-04-01       Impact factor: 4.730

8.  Prostaglandin E2 is activated by airway injury and regulates fibroblast cytoskeletal dynamics.

Authors:  Vlad C Sandulache; Tripti Singh; Ha Sheng Li-Korotky; Chia Y Lo; Todd D Otteson; Mark Barsic; Joseph E Dohar; Patricia A Hebda
Journal:  Laryngoscope       Date:  2009-07       Impact factor: 3.325

9.  Cyclooxygenase-2 inhibition for the prevention of subglottic stenosis.

Authors:  Selma Cetin; Allison B Tobey; Vlad C Sandulache; Tianbing Yang; Mark Barsic; Yan Lin; Joseph E Dohar; Patricia A Hebda
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-10

10.  Wound trauma mediated inflammatory signaling attenuates a tissue regenerative response in MRL/MpJ mice.

Authors:  Stephen R Zins; Mihret F Amare; Khairul Anam; Eric A Elster; Thomas A Davis
Journal:  J Inflamm (Lond)       Date:  2010-05-25       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.